tiprankstipranks
Trending News
More News >
Gt Biopharma, Inc. (DE:OXIA)
:OXIA
Germany Market

GT Biopharma (OXIA) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Buy
2Bullish
1Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
2Neutral
2Bearish
Gt Biopharma, Inc.’s (OXIA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Gt Biopharma, Inc. is a Neutral.
Gt Biopharma, Inc.’s (OXIA) 20-Day exponential moving average is 4.77, while Gt Biopharma, Inc.’s (OXIA) share price is €4.77, making it a Buy.
Gt Biopharma, Inc.’s (OXIA) 50-Day exponential moving average is 4.77, while Gt Biopharma, Inc.’s (OXIA) share price is €4.77, making it a Sell.

GT Biopharma (OXIA) Pivot Points

May 18, 2025, 01:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.65
4.21
4.49
5.05
5.33
5.89
6.17
Fibonacci
4.21
4.53
4.73
5.05
5.37
5.57
5.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GT Biopharma (OXIA) Moving Averages

May 18, 2025, 01:23 PM
Period
Simple
Exponential
MA5
4.77Neutral
4.77Neutral
MA10
4.77Buy
4.77Buy
MA20
4.77Buy
4.77Buy
MA50
4.77Sell
4.77Sell
MA100
4.77Buy
4.77Buy
MA200
4.77Buy
4.77Buy
Gt Biopharma, Inc.’s (OXIA) 10-Day exponential moving average is 4.77, while Gt Biopharma, Inc.’s (OXIA) share price is €4.77, making it a Buy.
Gt Biopharma, Inc.’s (OXIA) 100-Day exponential moving average is 4.77, while Gt Biopharma, Inc.’s (OXIA) share price is €4.77, making it a Buy.
Gt Biopharma, Inc.’s (OXIA) stock price is €4.77 and Gt Biopharma, Inc.’s (OXIA) 50-day simple moving average is 4.77, creating a Sell signal.
Gt Biopharma, Inc.’s (OXIA) stock price is €4.77 and Gt Biopharma, Inc.’s (OXIA) 100-day simple moving average is 4.77, creating a Buy signal.
Gt Biopharma, Inc.’s (OXIA) stock price is €4.77 and Gt Biopharma, Inc.’s (OXIA) 200-day simple moving average is 4.77, creating a Buy signal.

GT Biopharma (OXIA) Technical Indicators

May 18, 2025, 01:23 PM
Name
Value
Implied Action
RSI (14)
100.00
Sell
STOCH (9,6)
0.00
-
STOCHRSI (14)
0.00
-
MACD (12,26)
<0.01
Neutral
ADX (14)
7.69
Buy
Williams %R
-100.00
Buy
CCI (14)
0.00
-
ATR (14)
0.84
-
Ultimate Oscillator
0.00
-
ROC
0.00
-
Gt Biopharma, Inc.’s (OXIA) Relative Strength Index (RSI) is 100.00, creating a Sell signal.
Gt Biopharma, Inc.’s (OXIA) Trend Strength Indicator (ADX) is 7.69, creating a Buy signal.

FAQ

Is OXIA a Buy, Hold, or Sell?
Based on OXIA’s technical indicators, OXIA is a Buy.
    What is OXIA’s RSI (14)?
    OXIA’s RSI (14) is 100.00, which suggests OXIA is a Sell.
      What is OXIA’s MACD?
      OXIA’s MACD is <0.01, which suggests OXIA is a Neutral.
        What is OXIA’s 5-day moving average?
        OXIA’s 5-day moving average is 4.77, which suggests OXIA is a Neutral.
          What is OXIA’s 20-day moving average?
          OXIA 20-day moving average is 4.77, which suggests OXIA is a Buy.
            What is OXIA’s 50-day moving average?
            OXIA’s 50-day moving average is 4.77, which suggests OXIA is a Sell.
              What is OXIA’s 200-day moving average?
              OXIA’s 200-day moving average is 4.77, which suggests OXIA is a Buy.
                What is OXIA’s Williams % R (14)?
                OXIA’s Williams % R (14) is -100.00, which suggests OXIA is a Buy.
                  What is OXIA’s CCI (14)?
                  Currently, no data Available
                  What is the share price of Gt Biopharma, Inc.?
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis